United-Guardian, Inc. (UG)
- Previous Close
8.42 - Open
8.20 - Bid --
- Ask --
- Day's Range
8.00 - 8.37 - 52 Week Range
5.79 - 10.23 - Volume
12,449 - Avg. Volume
8,819 - Market Cap (intraday)
38.471M - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
14.95 - EPS (TTM)
0.56 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield 0.35 (4.18%)
- Ex-Dividend Date Feb 9, 2024
- 1y Target Est
--
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
www.u-g.com23
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UG
Performance Overview: UG
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UG
Valuation Measures
Market Cap
38.47M
Enterprise Value
29.38M
Trailing P/E
14.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.53
Price/Book (mrq)
3.38
Enterprise Value/Revenue
2.70
Enterprise Value/EBITDA
9.90
Financial Highlights
Profitability and Income Statement
Profit Margin
23.71%
Return on Assets (ttm)
15.19%
Return on Equity (ttm)
25.00%
Revenue (ttm)
10.89M
Net Income Avi to Common (ttm)
2.58M
Diluted EPS (ttm)
0.56
Balance Sheet and Cash Flow
Total Cash (mrq)
9.09M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.22M